Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Neuro-Oncology
|
December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank
Pavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Cancer Research
|
September 17, 2020
Cancers from Novel <i>Pole</i>-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade
Melissa A Galati, Karl P Hodel, Miki S Gams, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Nature Cancer
|
May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Elizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Arxiv
|
December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials
Kartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Nature Communications
|
February 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways
Mark W Youngblood, Shashwat Tripathi, Hinda Najem, et al.
Cell
|
October 24, 2017
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany B Campbell, Nicholas Light, David Fabrizio, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Neuro-Oncology
|
December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank
Pavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Cancer Research
|
September 17, 2020
Cancers from Novel <i>Pole</i>-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade
Melissa A Galati, Karl P Hodel, Miki S Gams, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Nature Cancer
|
May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
Elizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Arxiv
|
December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials
Kartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Nature Communications
|
February 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways
Mark W Youngblood, Shashwat Tripathi, Hinda Najem, et al.
Cell
|
October 24, 2017
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany B Campbell, Nicholas Light, David Fabrizio, et al.
Page
of 15